CLINICAL CASE OF THROMBOLYTIC THERAPY OF RECURRENT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENT WITH LONG HISTORY OF ISCHEMIC HEART DISEASE
https://doi.org/10.20996/1819-6446-2016-12-3-302-305
Abstract
Presented case report demonstrates the efficacy and safety of hospital use of thrombolytic agent Fortelizin in pharmaco-invasive strategy for the treatment of a patient with acute myocardial infarction and with a long history of ischemic heart disease and long-term dynamics of the verified angiographic progression of coronary atherosclerosis. Hospital thrombolytic therapy with Fortelizin was vital alternative in case of a substantial time delay in mechanical reperfusion of the myocardium.
About the Authors
N. T. Vatutin
Institute of Emergency and Reconstructive Surgery. Leninsky prosp. 47, Donetsk, 283045 Ukraine
Donetsk State Medical University. Ilyicha prosp. 16, Donetsk, 283003 Ukraine
Ukraine
Ukraine
V. B. Kostogryz
Institute of Emergency and Reconstructive Surgery. Leninsky prosp. 47, Donetsk, 283045 Ukraine
Ukraine
Ukraine
A. I. Kostogryz
City hospital number 4. Chelyuskintsev ul. 186a, Donetsk, 283015 Ukraine
Ukraine
Ukraine
O. I. Stolika
Institute of Emergency and Reconstructive Surgery. Leninsky prosp. 47, Donetsk, 283045 Ukraine
Ukraine
Ukraine
References
1. Antman EM, Braunwald E. ST elevation myocardial infarction: Pathology, Pathophysiology and Clinical Features. In: Libby P, Bonow RO, Mann DL, et al. (Eds). Braunwald’s Heart Disease — A textbook of Cardiovascular Medicine. 8th ed. Philadelphia: Elsevier Saunders; 2008:1210-76.
2. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014 Oct 1;35(37):2541-619.
3. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33(20):2569-619.
4. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34(38):2949-3003.
Review
For citations:
Vatutin N.T., Kostogryz V.B., Kostogryz A.I., Stolika O.I. CLINICAL CASE OF THROMBOLYTIC THERAPY OF RECURRENT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENT WITH LONG HISTORY OF ISCHEMIC HEART DISEASE. Rational Pharmacotherapy in Cardiology. 2016;12(3):302-305. https://doi.org/10.20996/1819-6446-2016-12-3-302-305
Views:
1022
.jpg)
Email this article 